Article info
Editorial
Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer
- Correspondence to Dr David Cibula, Dept of Obstetrics and Gynecology, University of Prague, Prague 128 51, Czech Republic; dc{at}davidcibula.cz
Citation
Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer
Publication history
- Received August 8, 2022
- Accepted August 12, 2022
- First published September 13, 2022.
Online issue publication
October 03, 2022
Article Versions
- Previous version (13 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.